ERA PerMed, a new ERA-Net Cofund Action on Personalised Medicine (PM) has launched its first joint transnational Call for proposals. Deadline for pre-proposals is Tuesday, 10 April 2018, 17:00 CET.
ERA PerMed (2017-2022) is supported by 31 partners of 22 countries and co-funded by the European Commission.
It aims to align national and regional research strategies and funding activities, promoting excellence, reinforcing the competitiveness of European players in PM, and enhance the collaboration with non-EU countries.
The objective of the Call is to support translational research projects in the field of Personalised Medicine and to encourage and enable interdisciplinarity, in combining pre-clinical and/or clinical research with bio-informatics components.
ERA PerMed is thereby closely linked to ICPerMed and will foster the implementation of the ICPerMed Action Plan by funding transnational research projects in the field of PM.
The FNR supports this multilateral Call with 300,000 EUR as part of its INTER programme to foster international collaboration between researchers based in Luxembourg and abroad.
IC PerMed ‘Best Practice in Personalised Medicine Award’ 2018
The International Consortium for Personalised Medicine (ICPerMed) will be giving out an award for ‘Best Practice in Personalised Medicine’. The objective of this award is to encourage and disseminate best practice examples in personalised medicine.
The 2018 Award aims to recognise, encourage, promote and disseminate outstanding examples of best practices in personalised medicine.
These best practice examples can consist of one or several of the following:
- Scientific paper focused on novel approaches for the implementation of PM
- Training programmes for health personnel, increasing the level of awareness on the potential of PM
- Examples for interdisciplinary or intersectoral groups of collaboration (governmental and non-governmental organisations, academic management, medical research and health care), for the implementation of PM, including ELSI activities.
Individuals who have published scientific papers and/or developed best practice strategies in the field of PM between 1 January, 2016 and 31 December 2017, from any of the ICPerMed partner countries, are eligible to apply.
The awardee(s) will be invited to the ICPerMed Conference 2018 and will be given the opportunity to present their results during a plenary session to stakeholders interested in the area of PM. In addition, the successful candidates will receive a non-cash award of 500 EUR to support the dissemination of the awarded best practice example.
Deadline to apply is Friday, 2 March 2018.
Find out more about the IC PerMed ‘Best Practice in Personalised Medicine Award’ 2018